Trial intelligence / Profile preview

Melatonin for Migraine Prevention

NCT00849511Phase 2Completed

Sponsor
Nordlandssykehuset
Start
Feb 2009
Primary completion
Sep 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of melatonin in migraine, sponsored by Nordlandssykehuset. Started Feb 2009; status: completed.

02

Drugs

melatonin
03

Conditions

migraine

Beyond the preview

Go deeper on NCT00849511.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00849511.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call